Institutional shares held 36.1 Million
751K calls
568K puts
Total value of holdings $4.06B
$84.3M calls
$63.7M puts
Market Cap $4.7B
42,878,000 Shares Out.
Institutional ownership 84.28%
# of Institutions 409


Latest Institutional Activity in AXSM

Top Purchases

Q2 2025
J. Safra Sarasin Holding Ag Shares Held: 19.7K ($2.16M)
Q2 2025
Knights Of Columbus Asset Advisors LLC Shares Held: 19.9K ($2.18M)
Q2 2025
Pallas Capital Advisors LLC Shares Held: 37.8K ($4.14M)
Q2 2025
Nbc Securities, Inc. Shares Held: 2.61K ($286K)
Q2 2025
Ameritas Advisory Services, LLC Shares Held: 735 ($80.6K)

Top Sells

Q2 2025
Assenagon Asset Management S.A. Shares Held: 181K ($19.8M)
Q2 2025
Hb Wealth Management, LLC Shares Held: 24.9K ($2.74M)
Q2 2025
Janney Montgomery Scott LLC Shares Held: 13K ($1.43M)
Q2 2025
Forbes J M & CO LLP Shares Held: 3.7K ($406K)
Q2 2025
Gamma Investing LLC Shares Held: 64 ($7.02K)

About AXSM

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. It is also developing AXS-07, a novel, oral, rapidly absorbed, multi-mechanistic, and investigational medicine that has completed two Phase III trials for the acute treatment of migraine; AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is in Phase III trial to treat narcolepsy; and AXS-14, a novel, oral, and investigational medicine that is in Phase III trial for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.


Insider Transactions at AXSM

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
218K Shares
From 5 Insiders
Exercise of conversion of derivative security 218K shares
Sell / Disposition
186K Shares
From 5 Insiders
Open market or private sale 186K shares

Track Institutional and Insider Activities on AXSM

Follow Axsome Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXSM shares.

Notify only if

Insider Trading

Get notified when an Axsome Therapeutics, Inc. insider buys or sells AXSM shares.

Notify only if

News

Receive news related to Axsome Therapeutics, Inc.

Track Activities on AXSM